Bioventix (LON:BVXP) Issues Earnings Results

Bioventix (LON:BVXP) posted its quarterly earnings results on Monday. The biotechnology company reported GBX 72.27 ($0.93) earnings per share for the quarter, Digital Look Earnings reports. Bioventix had a return on equity of 69.09% and a net margin of 59.51%.

Bioventix Stock Down 1.0 %

Shares of Bioventix stock traded down GBX 25 ($0.32) on Wednesday, reaching GBX 2,400 ($31.03). 22,239 shares of the stock were exchanged, compared to its average volume of 6,032. Bioventix has a twelve month low of GBX 2,350 ($30.38) and a twelve month high of GBX 4,800 ($62.06). The business has a 50 day moving average price of GBX 2,879.90 and a two-hundred day moving average price of GBX 3,347.62. The firm has a market capitalization of £125.67 million, a price-to-earnings ratio of 15.52 and a beta of 0.35.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.